Summary
A 20 years old man with peripheral primitive neuroectodermal tumor involving the bone marrow received 12 Gy fractionated total body irradiation, 140 mg/m2 melphalan, 1800 mg/m2 etoposide, and 1500 mg/m2 carboplatin for consolidation of first remission. Thereafter, 250µg/m2/day recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) (Behring Werke) were administered as continuous infusion 4 days after infusion of autologous bone marrow and peripheral stem cells to accelerate granulocyte reconstitution for control of a continued febrile state. The clinical picture of capillary leak syndrome developed with weight gain, pleural effusions and peripheral edema. The patient's condition stabilized after discontinuation of rh GM-CSF. Eight days later he died of invasive aspergillosis. The clinical course of our patient suggests a potentially fatal toxic effect of rh GM-CSF, even in low dose, in the setting of septicemia or fungemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blazar BR, Kersey JH, McGlave PB, Vallera DA, Lasky LC, Haake RJ, Bostrom B, Weisdorf DR, Epstein C, Ramsay NK (1989) In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. Blood 73: 849–857
Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH (1988) Effect of recombinant human granulocyte-macrophage colonystimulating factor on hematopoietic reconstitution after highdose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–876
Ganser A, Völkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes — A phase I/II trial. Blood 73: 31–37
Herberman RB (1989) Interleukin-2 therapy of human cancer. Potential benefits versus toxicity. J Clin Oncol 7: 1–4
Klausmann M, Pflüger KH, Krumwieh D, Seiler FR, Havemann K (1988) Modulation of functions of granulocytes by recombinant human GM-CSF and possible complications of GM-CSF therapy. Leukemia 2 (Suppl): 63 S-72 S
Monroy RL, Skelly RR, Mac Vittie TJ, Davis TA, Sauber JJ, Clark SC, Donahue RE (1987) The effect of recombinant GMCSF on the recovery of monkeys transplanted with autologous bone marrow. Blood 70: 1696–1699
Nemunaitis J, Singer JW, Buckner CD, Hill RH, Storb R, Thomas ED, Appelbaum FR (1988) Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72: 834–836
Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 137: 1735–1742
Sisson SD, Dinarello CA (1988) Production of interleukin-la, interleukin-1 β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colonystimulating factor. Blood 72: 1368–1374
Sozinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L, Griffin JD (1988) Granulocyte-macrophage colony-stimulating factor induces the expression of the CD 11b surface adhesion molecule on human granulocytes in vivo. Blood 72: 691–697
Strauss GR (1987) Granulocyte transfusions: Uses, abuses and indications. In: Kolins J, Mc Carthy LJ (eds). Contemporary transfusion practice. American Association of Blood Banks, Arlington, VA, pp 65–83
Vadhan-Raj S, Keating M, Le Maistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer JE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocytemacrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317: 1545–1552
Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK (1989) Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor a and interferon in cancer patients. Blood 73: 643–646
Wright DG, Robichaud KF, Pizzo PA, Deisseroth AB (1981) Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med: 1185–1189
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emminger, W., Emminger-Schmidmeier, W., Peters, C. et al. Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state. Blut 61, 219–221 (1990). https://doi.org/10.1007/BF01744134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01744134